Detalhe da pesquisa
1.
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.
Leukemia
; 32(2): 383-390, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761118
2.
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma.
J Cancer Res Clin Oncol
; 135(4): 637-42, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941780